NeuroOne Medical Technologies Statistics
Want to see NMTC full AI Analyst Report?
NeuroOne Medical Technologies (NMTC) Stock Statistics & Valuation Metrics
Total Valuation
NeuroOne Medical Technologies has a market cap or net worth of $6.81M. The enterprise value is $24.70M.
- Market Cap
- $6.81M
- Enterprise Value
- $24.70M
Share Statistics
NeuroOne Medical Technologies has 9,105,763 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 9,105,763
- Owned by Insiders
- 22.48%
- Owned by Institutions
- 18.32%
Financial Efficiency
NeuroOne Medical Technologies’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -49.11%.
- Return on Equity (ROE)
- -0.51
- Return on Assets (ROA)
- -0.33
- Return on Invested Capital (ROIC)
- -49.11%
- Return on Capital Employed (ROCE)
- -0.50
- Revenue Per Employee
- 672.09K
- Profits Per Employee
- -200.30K
- Employee Count
- 18
- Asset Turnover
- 1.12
- Inventory Turnover
- 1.78
Valuation Ratios
The current PE Ratio of NeuroOne Medical Technologies is -0.82. NeuroOne Medical Technologies’s PEG ratio is 0.01.
- PE Ratio
- -0.82
- PS Ratio
- 0.68
- PB Ratio
- 1.71
- Price to FCF
- -0.95
- Price to Operating Cash Flow
- -0.92
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, NeuroOne Medical Technologies had revenue of 12.10M and earned -3.61M in profits. Earnings per share was -0.54.
- Revenue
- 12.10M
- Gross Profit
- 8.14M
- Operating Income
- -4.23M
- Pretax Income
- -3.61M
- Net Income
- -3.61M
- EBITDA
- -3.01M
- Earnings Per Share (EPS)
- -0.54
Cash Flow
In the last 12 months, operating cash flow was -7.05M and capital expenditures -109,539, giving a free cash flow of -7.16M billion.
- Operating Cash Flow
- -7.05M
- Free Cash Flow
- -7.16M
- Free Cash Flow per Share
- -0.83
Dividends & Yields
NeuroOne Medical Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -105.55%
- Earnings Yield
- -110.77%
Stock Price Statistics
- Beta
- 1.47
- 52-Week Price Change
- -81.68%
- 50-Day Moving Average
- 1.16
- 200-Day Moving Average
- 2.99
- Relative Strength Index (RSI)
- 32.38
- Average Volume (3m)
- 336.97K
Important Dates
NeuroOne Medical Technologies upcoming earnings date is Dec 16, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 19, 2026
- Next Earnings Date
- Dec 16, 2026
- Ex-Dividend Date
- ―
Financial Position
NeuroOne Medical Technologies as a current ratio of 4.44, with Debt / Equity ratio of 3.77%
- Current Ratio
- 4.44
- Quick Ratio
- 3.47
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 2.09
- Interest Coverage Ratio
- -12.65
Taxes
In the past 12 months, NeuroOne Medical Technologies has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
NeuroOne Medical Technologies EV to EBITDA ratio is -0.70, with an EV/FCF ratio of -0.67.
- EV to Sales
- 0.48
- EV to EBITDA
- -0.70
- EV to Free Cash Flow
- -0.67
- EV to Operating Cash Flow
- -0.68
Balance Sheet
NeuroOne Medical Technologies has $2.05M in cash and marketable securities with $73.32K in debt, giving a net cash position of $1.97M billion.
- Cash & Marketable Securities
- $2.05M
- Total Debt
- $73.32K
- Net Cash
- $1.97M
- Net Cash Per Share
- $0.22
- Tangible Book Value Per Share
- $0.43
Margins
Gross margin is 55.67%, with operating margin of -76.05%, and net profit margin of -71.51%.
- Gross Margin
- 55.67%
- Operating Margin
- -76.05%
- Pretax Margin
- -71.51%
- Net Profit Margin
- -71.51%
- EBITDA Margin
- -69.14%
- EBIT Margin
- -71.51%
Analyst Forecast
The average price target for NeuroOne Medical Technologies is $6.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $6.50
- Price Target Upside
- 772.48% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- -1.67%
- EPS Growth Forecast
- 7.34%
Scores
- Smart Score
- ―
- AI Score
- 47
